Zomedica Corp. Common Shares (ZOM)
0.0973
+0.00 (0.00%)
NYSE · Last Trade: Dec 15th, 5:05 PM EST
Detailed Quote
| Previous Close | 0.0973 |
|---|---|
| Open | - |
| Bid | 0.0970 |
| Ask | 0.0984 |
| Day's Range | N/A - N/A |
| 52 Week Range | 0.0943 - 0.1580 |
| Volume | 0 |
| Market Cap | 95.35M |
| PE Ratio (TTM) | -0.9730 |
| EPS (TTM) | -0.1 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
About Zomedica Corp. Common Shares (ZOM)
Zomedica Pharmaceuticals Corp is a veterinary-focused healthcare company dedicated to developing innovative diagnostic and therapeutic products for companion animals, particularly dogs and cats. The company aims to enhance the quality of care for pets and improve their health outcomes through its advanced diagnostic tools. Zomedica's flagship product line includes diagnostics that help veterinarians detect and monitor various health conditions, empowering them to make informed decisions regarding treatment options. With a commitment to improving animal health, Zomedica seeks to support veterinary practices with effective solutions that ultimately lead to better pet care. Read More
News & Press Releases
The collaboration highlights Zomedica's commitment to expanding pet wellness education as Assisi Loop technology is featured in the highly anticipated movie Merv now available on Prime Video
Via ACCESS Newswire · December 11, 2025
Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment
Via ACCESS Newswire · December 4, 2025
November session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars
Via ACCESS Newswire · November 11, 2025
Certification enhances global market readiness, reinforces quality systems, and supports Zomedica's long-term growth strategy
Via ACCESS Newswire · November 6, 2025
Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter!
Via ACCESS Newswire · November 4, 2025

Zomedica's ticker symbol will change to ZOMDF
Via ACCESS Newswire · March 4, 2025
Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's leadership in targeted tPEMF innovation
Via ACCESS Newswire · October 23, 2025
Expanded agreement strengthens Zomedica's European presence, broadens product portfolio on the market, and positions the Company to capture growth in the multi-billion-dollar global veterinary diagnostics and therapeutic device markets
Via ACCESS Newswire · October 14, 2025
Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities
Via ACCESS Newswire · October 9, 2025
First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients
Via ACCESS Newswire · September 23, 2025
Intellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the rapidly growing multi-billion dollar veterinary diagnostics market
Via ACCESS Newswire · September 18, 2025
Cutting-Edge Digital Microscopy System Featured in Monthly Series Showcasing Innovation in Veterinary Care
Via ACCESS Newswire · September 12, 2025
Agreement strengthens Canadian veterinarians' access to Zomedica's advanced therapeutic and monitoring solutions
Via ACCESS Newswire · September 10, 2025
Strategic partnership with Pioneer Veterinary Products Limited expands Zomedica's presence in the UK veterinary market through distribution of its leading point-of-care solutions
Via ACCESS Newswire · September 3, 2025
New agreement brings innovative shock wave, tPEMF therapy, monitoring, and bleeding control solutions to more than 2,200 member clinics nationwide
Via ACCESS Newswire · August 19, 2025
Revolutionary Plant-Based Technology Gains Momentum as a Game-Changer in Wound Management
Via ACCESS Newswire · August 12, 2025
Zomedica posts record year-over-year revenue for 18th straight quarter!
Via ACCESS Newswire · August 6, 2025
Breakthrough tPEMF™ Technology Showcased in Monthly Series Exploring Innovation in Veterinary Care
Via ACCESS Newswire · July 16, 2025
Elevating Equine Health and Show Experience with Leading Shock Wave Therapy
Via ACCESS Newswire · July 10, 2025
Intellectual Property Portfolio grows to 221 Patents and 140 Trademarks
Via ACCESS Newswire · June 24, 2025
Next-Generation Diagnostic Platform Takes Center Stage in Monthly Series Showcasing Innovation in Veterinary Care
Via ACCESS Newswire · June 19, 2025
The TRUFORMA Platform now has the widest dynamic range (without manual dilution) available either at the Point of Care or from a Reference Lab
Via ACCESS Newswire · May 21, 2025
Engaging Sessions to Highlight Game-Changing Technologies, Expert Insights, and Growth Opportunities in Animal Health Featuring Zomedica Products
Via ACCESS Newswire · May 19, 2025
Innovative Registry Harnesses Shock Wave Therapy to Advance Non-Drug Equine Asthma Treatment and Drive Evidence-Based Veterinary Care
Via ACCESS Newswire · May 13, 2025